Stimulant Laxative Plus Stool Softener Tablet, Film Coated
NDC Package 17856-1248-1
Package Information
Stimulant Laxative Plus Stool Softener (docusate sodium 50 mg and sennosides 8.6 mg) tablets is take only by mouth. This formulation utilizes a tablet, film coated delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-1248 and is authorized under FDA application M.
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-1248 - Stimulant Laxative Plus Stool Softener
- 17856-1248-1 - 100 POUCH in 1 BOX, UNIT-DOSE / 1 TABLET, FILM COATED in 1 POUCH
- 17856-1248 - Stimulant Laxative Plus Stool Softener
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-1248-1 identifies a specific commercial package of 100 pouch in 1 box, unit-dose / 1 tablet, film coated in 1 pouch of Stimulant Laxative Plus Stool Softener, a human over the counter drug labeled by Atlantic Biologicals Corp.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet, film coated is formulated for oral use and contains docusate sodium; sennosides as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on October 22, 2019. The current certification is valid through December 31, 2026.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856124801. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.